The Plus SideZ: A GLP-1 Guide to Metabolic Health Podcast By Kim Carlos cover art

The Plus SideZ: A GLP-1 Guide to Metabolic Health

The Plus SideZ: A GLP-1 Guide to Metabolic Health

By: Kim Carlos
Listen for free

Prime Member Exclusive | $0.99/mo for 4 months

$8.99/mo thereafter—terms apply.

Looking for real information on GLP-1 medications and weight loss? You’re in the right place.


The Plus SideZ Podcast is your go-to space for science-backed conversations about obesity treatment, weight loss, and living with a chronic metabolic disorder. Hosted by Kim Carlos and Kat Carter, we explore GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound, featuring insights from leading obesity specialists, endocrinologists, and bariatric surgeons. But this podcast is about more than just medication—it’s about navigating the mental, emotional, and physical journey of reclaiming your health.


We combat misinformation with education from top experts, helping you think critically about the latest research, treatment options, and systemic challenges in obesity care. And at the heart of it all are the powerful, vulnerable stories of our brave community members—people sharing their real experiences on GLP-1 medications, breaking stigma, and taking control of their health.


Ranked in the top 1% of podcasts globally, The Plus SideZ Podcast has won three awards in just 18 months, including two Anthem Awards for social impact. Featured on Good Morning America, Bloomberg News, and ABC Nightline on Hulu, we’re at the forefront of the conversation on weight loss, obesity care, and the fight to end weight bias.


Join us and be part of a movement that’s changing the way the world understands obesity, health, and metabolic wellness.


Our Linktree

https://linktr.ee/theplussidez


Want to donate?

PayPal
https://www.paypal.com/donate/?hosted_button_id=ZSEE2DRPHDSZN

GoFundMe
https://gofund.me/82c8138e

Shop The Plus SideZ Merch Store
https://the-plus-sidez-podcast.printify.me/products/1

Website
https://theplussidez.com/

© 2026 The Plus SideZ: A GLP-1 Guide to Metabolic Health Hygiene & Healthy Living Personal Development Personal Success Physical Illness & Disease
Episodes
  • The World Has More GLP-1s but Who Can Afford Them? Part 2

    The World Has More GLP-1s but Who Can Afford Them? Part 2
    Sep 8 2026
    Linktree - our favorite links (https://linktr.ee/dinosaurmonkeyfarts) NEW: Need GLP-1 Care? Join me at Belle! Use Podcast at checkout to save! https://link.joinbelle.com/podcast NEW: Cozy Butter GLP-1 Community! Join Free (https://cozybutter.com/) https://cozybutter.com/A GLP-1 community where support isn’t at the mercy of the algorithm.Live GLP-1 support groupsLive support groups and social eventsHealth coaching and expert Q&AsCooking, movement, and stress-management classesGLP-1 tools and guidance (water, protein, side effect management, etc.) A dedicated community beyond the algorithmBook at 1 on 1 with Kim (https://calendly.com/theplussidez/kim...) The World Has More GLP-1s but Who Can Afford Them? Part 2This week’s GLP-1 news had us thinking about access. Oral Wegovy launched in Germany, and Hims & Hers expanded its GLP-1 services into Australia. But in the U.S., PepsiCo announced it would cut obesity medication coverage while 600,000 people signed up for the new Medicare GLP-1 Bridge program. That is less than 1% of all Medicare beneficiaries, although we still do not know how many were approved or received medication.Four years after Mounjaro launched, are GLP-1s becoming easier to find but harder to get covered? It felt like the right time to revisit this Season 4 conversation with Dr. Michael “Mick” Crotty and Belinda Hogan about GLP-1 access, obesity care and weight bias around the world.In Part 2, we discuss:• Managing daily life and side effects on GLP-1 medication• Why weight loss slows and plateaus happen• How the body’s set point may affect weight• What GLP-1 maintenance really means• Balancing continued weight loss with stabilization• Adjusting treatment for long-term care• What Ireland could learn from the U.S. rollout of GLP-1 medicationsDr. Crotty is a GP, co-founder and clinical lead of My Best Weight in Ireland. Belinda shares her lived experience navigating GLP-1 side effects, plateaus, maintenance and long-term treatment.CONNECT WITH OUR GUESTSDr. Michael “Mick” CrottyMy Best Weighthttps://www.mybestweight.ie/Instagramhttps://www.instagram.com/mybestweight.ie/LinkedInhttps://ie.linkedin.com/in/drmichaelcrottyBelinda HoganInstagramhttps://www.instagram.com/mid.life.insights/The Dose with Paddy and Belindahttps://linktr.ee/TheDosePodcastSOURCESOral Wegovy launches in Germanyhttps://www.reuters.com/legal/litigation/novo-nordisk-launches-wegovy-weight-loss-pill-germany-2026-09-01/Hims & Hers expands its GLP-1 services into Australiahttps://www.reuters.com/business/healthcare-pharmaceuticals/hims-hers-offers-glp-1-weight-loss-drugs-mens-health-treatments-australia-2026-08-31/600,000 people sign up for the Medicare obesity drug programhttps://www.reuters.com/legal/litigation/600000-seniors-have-signed-up-obesity-drugs-under-new-medicare-program-2026-08-31/Employer GLP-1 coverage fell in 2026https://www.reuters.com/legal/litigation/more-us-employers-drop-weight-loss-drugs-2027-healthcare-costs-increase-2026-08-25/PepsiCo and other employers cut GLP-1 coveragehttps://abcnews.com/Health/companies-offering-coverage-glp-1-weight-loss-drugs/story?id=135999790Medicare enrollment datahttps://data.cms.gov/summary-statistics-on-beneficiary-enrollment/medicare-and-medicaid-reports/medicare-monthly-enrollmentSend us Fan Mail!Support the showKim Carlos, Executive Producer TikTokInstagram Kat Carter, Producer TikTokInstagram
    Show more Show less
    58 mins
  • BIG NEWS! We Deserve Better. So We Built It. 🧈

    BIG NEWS! We Deserve Better. So We Built It. 🧈
    Sep 4 2026

    I have exciting news!

    After 3 years of this podcast, interviewing obesity medicine experts and hearing from tens of thousands of you, I kept seeing the same gap between getting the prescription and the support we need to actually get to whatever our goal is.

    So my friend, fellow obesity care advocate and now partner, Amanda Bonello and I decided to do something about it.

    We built the Cozy Butter GLP-1 Community.

    It’s a place for live support, expert Q&As, health coaches, cooking classes, tools and resources built from cited sources, and most importantly, real connection with people who understand this journey.

    You can join us for free right now at CozyButter.com.

    Amanda and I built this for you because we believe you deserve better. And you shouldn’t have to figure this out alone.

    Welcome to The Butter Way. 🧈

    Send us Fan Mail!

    Support the show

    Kim Carlos, Executive Producer

    TikTok

    Instagram

    Kat Carter, Producer

    TikTok

    Instagram

    Show more Show less
    2 mins
  • The World Has More GLP-1s but Who Can Afford Them? Part 1

    The World Has More GLP-1s but Who Can Afford Them? Part 1
    Sep 1 2026
    Linktree - our favorite links NEW: Cozy Butter GLP-1 Community! Join Freehttps://cozybutter.com/A GLP-1 community where support isn’t at the mercy of the algorithm.- Live GLP-1 support groups- Live support groups and social events- Health coaching and expert Q&As- Cooking, movement, and stress-management classes- Practical GLP-1 tools and guidance (water, protein, side effect management, etc.) - A dedicated community beyond the algorithmBook at 1 on 1 with Kim ______________________________________________________________________The World Has More GLP-1s but Who Can Afford Them? Part 1 This week’s GLP-1 news had us thinking about access. Oral Wegovy launched in Germany, and Hims & Hers expanded its GLP-1 services into Australia. But in the U.S., PepsiCo announced it would cut obesity medication coverage while 600,000 people signed up for the new Medicare GLP-1 Bridge program. That is less than 1% of all Medicare beneficiaries, although we still do not know how many were approved or received medication.Four years after Mounjaro launched, are GLP-1s becoming easier to find but harder to get covered? It felt like the right time to revisit this Season 4 conversation with Dr. Michael “Mick” Crotty and Belinda Hogan about GLP-1 access, obesity care and weight bias around the world.In Part 1, we discuss:• How fat functions in the body and why it is considered an organ• GLP-1 access, costs and treatment criteria in Ireland• Which obesity medications were available in Ireland• Differences between obesity care in Ireland and the United States• Weight bias in healthcare and society• Why obesity requires medical care, not more blameDr. Crotty is a GP, co-founder and clinical lead of My Best Weight in Ireland. Belinda shares her lived experience using GLP-1 medication and navigating obesity care.CONNECT WITH OUR GUESTSDr. Michael “Mick” CrottyMy Best Weighthttps://www.mybestweight.ie/Instagramhttps://www.instagram.com/mybestweight.ie/LinkedInhttps://ie.linkedin.com/in/drmichaelcrottyBelinda HoganInstagramhttps://www.instagram.com/mid.life.insights/The Dose with Paddy and Belindahttps://linktr.ee/TheDosePodcastSOURCESOral Wegovy launches in Germanyhttps://www.reuters.com/legal/litigation/novo-nordisk-launches-wegovy-weight-loss-pill-germany-2026-09-01/Hims & Hers expands its GLP-1 services into Australiahttps://www.reuters.com/business/healthcare-pharmaceuticals/hims-hers-offers-glp-1-weight-loss-drugs-mens-health-treatments-australia-2026-08-31/600,000 people sign up for the Medicare obesity drug programhttps://www.reuters.com/legal/litigation/600000-seniors-have-signed-up-obesity-drugs-under-new-medicare-program-2026-08-31/Employer GLP-1 coverage fell in 2026https://www.reuters.com/legal/litigation/more-us-employers-drop-weight-loss-drugs-2027-healthcare-costs-increase-2026-08-25/PepsiCo and other employers cut GLP-1 coveragehttps://abcnews.com/Health/companies-offering-coverage-glp-1-weight-loss-drugs/story?id=135999790Medicare enrollment datahttps://data.cms.gov/summary-statistics-on-beneficiary-enrollment/medicare-and-medicaid-reports/medicare-monthly-enrollment______________________________________________________________________Join this channel to get access to perks:https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join_________________________________________________________________________#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovySend us Fan Mail!The Podcast Promo Ad Support the showKim Carlos, Executive Producer TikTokInstagram Kat Carter, Producer TikTokInstagram
    Show more Show less
    1 hr and 1 min
adbl_web_anon_alc_button_suppression_t1
All stars
Most relevant
The best health & wellness podcast, hands down! The hosts are very knowledgeable about GLP1 Medications (Ozempic, Wegovy, and Mounjaro). Especially Kim, who's manages to be both knowledgeable and entertaining! They bring in medical experts and address the negativity, stigma, and shame surrounding obesity (including the use of these medications)! Please recommend this podcast to anyone you think would find it inspirational or beneficial. It's been life changing for me. Combat misinformation with education!

Empowering & Informative GLP1 Heath & Wellness Podcast!

Something went wrong. Please try again in a few minutes.